LIFR and breast carcinoma: In addition, miR-197-3p inhibitor was also found to reverse the inhibitory effects of LIFR-AS1 on Sufu protein expression (Figure 6G) Our data indicate that miR-197-3p mediates the effects of LIFR-AS1 on breast cancer cell proliferation, migration and invasion.